Cargando…

Circulating Galectin-1 and Galectin-3 in Sera From Patients With Systemic Sclerosis: Associations With Clinical Features and Treatment

Systemic Sclerosis (SSc) is a rheumatic disease characterized by fibrosis, microvascular damage and immune dysregulation. Two major subsets, limited cutaneous systemic sclerosis (lcSSc) and diffuse cutaneous systemic sclerosis (dcSSc) can be defined, according to the extent of skin involvement. Incr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sundblad, Victoria, Gomez, Ramiro A., Stupirski, Juan C., Hockl, Pablo F., Pino, Maria S., Laborde, Hugo, Rabinovich, Gabriel A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093796/ https://www.ncbi.nlm.nih.gov/pubmed/33959016 http://dx.doi.org/10.3389/fphar.2021.650605

Ejemplares similares

Clinical Relevance of Galectin-1 and Galectin-3 in Rheumatoid Arthritis Patients: Differential Regulation and Correlation With Disease Activity
por: Mendez-Huergo, Santiago P., et al.
Publicado: (2019)

Circulating galectin-1 delineates response to bevacizumab in melanoma patients and reprograms endothelial cell biology
por: Bannoud, Nadia, et al.
Publicado: (2023)

Galectins in Intestinal Inflammation: Galectin-1 Expression Delineates Response to Treatment in Celiac Disease Patients
por: Sundblad, Victoria, et al.
Publicado: (2018)

Galectin-1 Facilitates Macrophage Reprogramming and Resolution of Inflammation Through IFN-β
por: Yaseen, Hiba, et al.
Publicado: (2020)

Galectin-1 Prevents Infection and Damage Induced by Trypanosoma cruzi on Cardiac Cells
por: Benatar, Alejandro F., et al.
Publicado: (2015)

Galectins in the Pathogenesis of Common Retinal Disease
por: Caridi, Bruna, et al.
Publicado: (2021)

Thwarting galectin-induced immunosuppression in breast cancer
por: Salatino, Mariana, et al.
Publicado: (2013)

Delineating the "galectin signature" of the tumor microenvironment
por: Compagno, Daniel, et al.
Publicado: (2013)

Galectin-1 expression imprints a neurovascular phenotype in proliferative retinopathies and delineates responses to anti-VEGF
por: Ridano, Magali E., et al.
Publicado: (2017)

A Dynamic Interplay of Circulating Extracellular Vesicles and Galectin-1 Reprograms Viral Latency during HIV-1 Infection
por: Rubione, Julia, et al.
Publicado: (2022)

Galectin-1 as a potential cancer target
por: Rabinovich, G A
Publicado: (2005)

Circulating galectin-3 promotes tumor-endothelium-adhesion by upregulating ICAM-1 in endothelium-derived extracellular vesicles
por: Wang, Lei, et al.
Publicado: (2022)

Eosinophil-expressed galectin-3 regulates cell trafficking and migration
por: Ge, Xiao Na, et al.
Publicado: (2013)

A Pro-resolving Role for Galectin-1 in Acute Inflammation
por: Law, Hannah L., et al.
Publicado: (2020)

Galectin-7 reprograms skin carcinogenesis by fostering innate immune evasive programs
por: Pinto, Nicolás A., et al.
Publicado: (2023)

Dual roles of endogenous and exogenous galectin-1 in the control of testicular immunopathology
por: Pérez, Cecilia V., et al.
Publicado: (2015)

Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression
por: Girotti, María Romina, et al.
Publicado: (2019)

The universe of galectin-binding partners and their functions in health and disease
por: Troncoso, María F., et al.
Publicado: (2023)

Galectin-1 is essential for efficient liver regeneration following hepatectomy
por: Potikha, Tamara, et al.
Publicado: (2016)

Placental Expression Patterns of Galectin-1, Galectin-2, Galectin-3 and Galectin-13 in Cases of Intrauterine Growth Restriction (IUGR)
por: Hutter, Stefan, et al.
Publicado: (2016)

"Time sweet time": circadian characterization of galectin-1 null mice
por: Casiraghi, Leandro P, et al.
Publicado: (2010)

Galectin-3, Possible Role in Pathogenesis of Periodontal Diseases and Potential Therapeutic Target
por: Velickovic, Milica, et al.
Publicado: (2021)

Transcriptional upregulation of galectin-3 in multiple sclerosis
por: Mangano, Katia, et al.
Publicado: (2023)

Galectins in Chagas Disease: A Missing Link Between Trypanosoma cruzi Infection, Inflammation, and Tissue Damage
por: Poncini, Carolina V., et al.
Publicado: (2022)

Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma
por: Videla-Richardson, Guillermo A., et al.
Publicado: (2021)

Overexpression of Galectin-1 and Galectin-3 in hepatocellular carcinoma
por: Setayesh, Tahereh, et al.
Publicado: (2020)

Growth hormone upregulates the pro-tumorigenic galectin 1 in mouse liver
por: Bacigalupo, María L, et al.
Publicado: (2019)

Growth hormone upregulates the pro-tumorigenic galectin 1 in mouse liver
por: Bacigalupo, María L, et al.
Publicado: (2021)

Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer
por: Cagnoni, Alejandro J., et al.
Publicado: (2016)

Galectin-1 as an Emerging Mediator of Cardiovascular Inflammation: Mechanisms and Therapeutic Opportunities
por: Seropian, Ignacio M., et al.
Publicado: (2018)

Galectin-3 Deletion Reduces LPS and Acute Colitis-Induced Pro-Inflammatory Microglial Activation in the Ventral Mesencephalon
por: Espinosa-Oliva, Ana M., et al.
Publicado: (2021)

A Synthetic Tetramer of Galectin-1 and Galectin-3 Amplifies Pro-apoptotic Signaling by Integrating the Activity of Both Galectins
por: Farhadi, Shaheen A., et al.
Publicado: (2020)

Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke
por: He, Xin-Wei, et al.
Publicado: (2017)

Galectins and Gliomas
por: Le Mercier, Marie, et al.
Publicado: (2009)

“Galectin-1 Induces Central and Peripheral Cell Death: Implications in T-Cell Physiopathology”
por: Sotomayor, C. E., et al.
Publicado: (2000)

Immunoprecipitation of spliceosomal RNAs by antisera to galectin-1 and galectin-3
por: Wang, Weizhong, et al.
Publicado: (2006)

Galectin-3 and galectin-3 binding protein in rheumatoid arthritis
por: Ohshima, S, et al.
Publicado: (2003)

Circulating Galectin‐3 Is Associated With Cardiometabolic Disease in the Community
por: Nayor, Matthew, et al.
Publicado: (2015)

Selective Myeloid Depletion of Galectin-3 Offers Protection Against Acute and Chronic Lung Injury
por: Humphries, Duncan C., et al.
Publicado: (2021)

Preprocedural circulating galectin-3 and the risk of mortality after transcatheter aortic valve replacement: a systematic review and meta-analysis
por: Zhang, Hong-liang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kuvvvt19qk108tl6irk9m7ecm6